Miller, C. R., Huang, Y., Allan, J. N., Bhat, S. A., Bond, D., Brander, D., … Kittai, A. S. (2025). Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era. Am J Hematol, 100(9), 1709–1713. https://doi.org/10.1002/ajh.27760

Miller, Cecelia R., Ying Huang, John N. Allan, Seema A. Bhat, David Bond, Danielle Brander, John C. Byrd, et al. “Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.” Am J Hematol 100, no. 9 (September 2025): 1709–13. https://doi.org/10.1002/ajh.27760.

Miller CR, Huang Y, Allan JN, Bhat SA, Bond D, Brander D, et al. Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era. Am J Hematol. 2025 Sep;100(9):1709–13.

Miller, Cecelia R., et al. “Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.” Am J Hematol, vol. 100, no. 9, Sept. 2025, pp. 1709–13. Pubmed, doi:10.1002/ajh.27760.

Miller CR, Huang Y, Allan JN, Bhat SA, Bond D, Brander D, Byrd JC, Chavez J, Chong E, Danilov A, Dowling MR, Dvorak-Kornaus K, Hampel PJ, Ho C, Islam P, Malakhov N, Matasar M, Miller S, Parikh SA, Rabe KG, Rhodes JM, Roeker LE, Rogers KA, Saha A, Skarbnik A, Scott H, Schade J, Shadman M, Shouse G, Sojitra P, Stephens DM, Thompson MC, Thompson PA, Wang Y, Woyach JA, Yano M, Omer Z, Kittai AS. Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era. Am J Hematol. 2025 Sep;100(9):1709–1713.